Advanced Accelerator Applications Announces FDA Priority Review for Lutathera

SAINT-GENIS-POUILLY, France, June 27, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear Medicine (MNM), today announced that the U.S. Food and...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news